78 citations
,
June 2005 in “Annals of oncology” This case study reported that a 74-year-old woman with metastatic rectal cancer experienced temporary trichomegaly, or eyelash lengthening, associated with cetuximab treatment, which resolved after discontinuation of the drug.
24 citations
,
July 2005 in “Journal of the American Academy of Dermatology” In this case report, the authors suggest that topiramate, used for treating bipolar disorder, may cause trichomegaly, or excessive eyelash growth, in patients.
15 citations
,
March 2009 in “Pediatric dermatology” This case report documents a novel occurrence of bilateral trichomegaly with alopecia areata in a healthy 3-year-old girl, without known underlying health conditions or medication use.
12 citations
,
November 2006 in “Journal of thoracic oncology” This case report describes a patient with non-small cell lung cancer who experienced trichomegaly (excessive eyelash growth) as a side effect of erlotinib treatment without developing typical skin rash.
3 citations
,
August 2019 in “Journal of Cancer Research and Therapeutics” This case report describes an unusual combination of hypertrichosis, androgenic alopecia, and trichomegaly in a patient with metastatic colon adenocarcinoma treated with cetuximab, with no adrenal or hormonal abnormalities detected.